SB202190 alleviates endometrial fibrosis by modulating the TGF-β/Smad signaling pathway
American Journal of Translational Research · 2026 · 18 (7) · 5954-5963
DOI: 10.62347/egye9400 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Yulan Ma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology, General Hospital of Ningxia Medical University Yinchuan 750004, Ningxia, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynaecology, General Hospital of Ningxia Medical University Yinchuan 750004, Ningxia, China.
Zitieren
APA
Ma, Y., Tian, Y., Meng, H., & Yang, C. (2026). SB202190 alleviates endometrial fibrosis by modulating the TGF-β/Smad signaling pathway. American Journal of Translational Research, 18(7), 5954-5963. https://doi.org/10.62347/egye9400
Vancouver
Ma Y, Tian Y, Meng H, Yang C. SB202190 alleviates endometrial fibrosis by modulating the TGF-β/Smad signaling pathway. American Journal of Translational Research. 2026;18(7):5954-5963. doi:10.62347/egye9400
BibTeX
@article{Ma2026,
author = {Ma, Yulan and Tian, Yanlan and Meng, Huanran and Yang, Caihang},
title = {SB202190 alleviates endometrial fibrosis by modulating the TGF-β/Smad signaling pathway},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {7},
pages = {5954--5963},
doi = {10.62347/egye9400}
}
EUVIMED